Results 11 to 20 of about 9,590,921 (389)

Pathological patterns of biliary disease. [PDF]

Clin Liver Dis (Hoboken), 2017
Lewis J.
europepmc   +5 more sources

Economic cost analysis of cholecystectomy based on development of specialization [PDF]

Waike lilun yu shijian, 2022
Object To analyze the difference of economics cost between biliary surgeons and general surgeons in performing cholecystectomy for gallbladder benign diseases and the influence of specialization of surgery on patients.
SHEN Sheng, GAO Zhihui, XIN Yanlei, ZHENG Bohao, LIU Houbao, SUO Tao
doaj   +1 more source

Comparison of the clinical features and long-term prognosis of gallbladder neuroendocrine carcinoma versus gallbladder adenocarcinoma: A propensity score-matched analysis

Biomolecules & Biomedicine, 2023
Gallbladder neuroendocrine carcinoma (GBNEC) is rare and characterized by a low degree of tumor differentiation. The clinical features of GBNEC versus gallbladder adenocarcinoma (GBADC) remain a subject of debate.
Ya-Fei Hu, Wen-Jie Ma, Hai-Jie Hu, Han-Fei Gu, Yan-Wen Jin, Fu-Yu Li   +5 more
doaj   +1 more source

Cholangioscopy for biliary diseases

Current Opinion in Gastroenterology, 2023
Purpose of review Cholangioscopy is a mini-invasive endoscopic procedure, which consists in a direct intraductal visualization of the biliary tract. The purpose of this review is to summarize the technique, the clinical applications, as well as future perspectives of cholangioscopy.
Becq, Aymeric, Soualy, Adil, Camus, Marine   +2 more
openaire   +3 more sources

Design and Development of a Disposable Superfine Catheter for Visual Examination of Bile Ducts and Related Animal Experiments

Frontiers in Surgery, 2022
ObjectiveTo design and develop a disposable superfine catheter system for visual examination of bile and pancreatic ducts and predict its clinical application value.MethodsThe superfine triple-lumen catheter and miniature photography technology were used
Jin-Yong Hao, Jin-Yong Hao, Yao-Ping Zhang, Xiao-Jun Huang, Xiao-Jun Huang   +4 more
doaj   +1 more source

Establishment and characterization of an immortalized epithelial cell line from human gallbladder

Frontiers in Oncology, 2022
BackgroundAlthough a plethora of studies have employed multiple gallbladder cancer (GBC) cell lines, it is surprisingly noted that there is still lack of a normal gallbladder epithelial cell line as a normal counterpart, thus impeding substantially the ...
Ziyi Wang, Ziyi Wang, Ziyi Wang, Ziyi Wang, Shijia Wang, Shijia Wang, Shijia Wang, Shijia Wang, Ziheng Jia, Ziheng Jia, Ziheng Jia, Ziheng Jia, Yuhao Zhao, Yuhao Zhao, Yuhao Zhao, Yuhao Zhao, Mao Yang, Mao Yang, Mao Yang, Mao Yang, Weikang Yan, Weikang Yan, Weikang Yan, Weikang Yan, Tao Chen, Tao Chen, Tao Chen, Tao Chen, Dongxi Xiang, Dongxi Xiang, Dongxi Xiang, Rong Shao, Rong Shao, Rong Shao, Rong Shao, Rong Shao, Yingbin Liu, Yingbin Liu, Yingbin Liu, Yingbin Liu   +39 more
doaj   +1 more source

Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit

Frontiers in Oncology, 2021
ObjectivesTo investigate the prognostic significance of the systemic immune-inflammation index (SII) in patients after radical cholecystectomy for gallbladder cancer (GBC) using overall survival (OS) as the primary outcome measure.MethodsBased on data ...
Lin Li, Lin Li, Lin Li, Lin Li, Tai Ren, Tai Ren, Tai Ren, Ke Liu, Ke Liu, Ke Liu, Ke Liu, Mao-Lan Li, Mao-Lan Li, Mao-Lan Li, Ya-Jun Geng, Ya-Jun Geng, Ya-Jun Geng, Ya-Jun Geng, Yang Yang, Yang Yang, Yang Yang, Yang Yang, Huai-Feng Li, Huai-Feng Li, Huai-Feng Li, Xue-Chuan Li, Xue-Chuan Li, Xue-Chuan Li, Xue-Chuan Li, Run-Fa Bao, Run-Fa Bao, Run-Fa Bao, Yi-Jun Shu, Yi-Jun Shu, Yi-Jun Shu, Hao Weng, Hao Weng, Hao Weng, Wei Gong, Wei Gong, Wei Gong, Wan Yee Lau, Xiang-Song Wu, Xiang-Song Wu, Xiang-Song Wu, Ying-Bin Liu, Ying-Bin Liu, Ying-Bin Liu, Ying-Bin Liu   +48 more
doaj   +1 more source

Statistical declarations versus scientific inferences and clinical judgments: the association of Glucagon-like peptide-1 receptor agonist use with the risk of biliary disease [PDF]

Frontiers in Endocrinology
David E. Most
doaj   +2 more sources

Publication Trends of Research on Gallbladder Cancer During 2001–2021: A 20-Year Bibliometric Analysis

Frontiers in Oncology, 2022
Gallbladder cancer (GBC) is one of the lethal cancers with an extremely poor prognosis. In the recent 20 years, research on GBC has developed rapidly.
Wentao Sun, Wentao Sun, Wentao Sun, Wenze Wan, Wenze Wan, Wenze Wan, Zhihui Gao, Zhihui Gao, Zhihui Gao, Tao Suo, Tao Suo, Tao Suo, Sheng Shen, Sheng Shen, Sheng Shen, Houbao Liu, Houbao Liu, Houbao Liu   +17 more
doaj   +1 more source

The oncogenic role of NF1 in gallbladder cancer through regulation of YAP1 stability by direct interaction with YAP1

Journal of Translational Medicine, 2023
Background Gallbladder cancer (GBC) is the most prevalent and invasive biliary tract malignancy. As a GTPase-activating protein, Neurofibromin 1 (NF1) is a tumor suppressor that negatively regulates the RAS signaling pathway, and its abnormality leads to
Lingxiao Zhang, Lin Jiang, Ling Zeng, Zhaohui Jin, Xuanjia Dong, Yuhan Zhang, Litian Chen, Yijun Shu, Yingbin Liu, Ying Huang   +9 more
doaj   +1 more source